For decades, cardio exercise dominated clinical advice for heart health, leaving resistance training treated as a secondary, aesthetic concern — especially for women. New evidence published in JAMA repositions strength training as a meaningful frontline intervention for cardiovascular risk reduction in female populations, a finding with real implications for how exercise prescriptions are written.
The study found a significant association between regular resistance training and reduced cardiovascular disease incidence in women. The analysis drew on a substantial cohort, tracking participants over time and capturing outcomes including coronary heart disease and stroke. Women who engaged in muscle-strengthening activity demonstrated meaningfully lower CVD event rates compared to those with no resistance training exposure, with the association holding even after adjustment for aerobic activity levels — suggesting an independent protective effect rather than a proxy for overall fitness.
This research fits into a rapidly maturing body of evidence on resistance training's systemic benefits beyond musculoskeletal health. Mechanistically, strength training improves insulin sensitivity, reduces visceral adiposity, lowers resting blood pressure, and favorably alters lipid profiles — all established CVD risk factors. What makes this study noteworthy is the sex-specific focus: most landmark exercise-cardiovascular studies have been conducted in predominantly male cohorts, leaving women underrepresented in the evidence base. If confirmed, this shifts resistance training from an optional supplement to aerobic activity into a near-essential component of cardiovascular prevention for women. Key limitations worth noting include the observational design, which precludes causal inference, reliance on self-reported physical activity, and potential residual confounding from socioeconomic or behavioral factors correlated with exercise habits. This is confirmatory and strengthening evidence rather than a paradigm shift, but its publication in JAMA with a female-specific lens gives it genuine clinical weight.
